Zhejiang Anglikang Pharmaceutical Co Ltd Class A Financial Flexibility Index
Zhejiang Anglikang Pharmaceutical Co Ltd Class A financial flexibility index. Zhejiang Anglikang Pharmaceutical Co Ltd Class A (002940) has a Financial Flexibility Index of 0.12x as of September 2025. Free cash flow of CN¥129.23 Million (operating CF CN¥112.57 Million minus capex CN¥16.66 Million) represents 0% of total liabilities (CN¥1.10 Billion). See Zhejiang Anglikang Pharmaceutical Co Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Zhejiang Anglikang Pharmaceutical Co Ltd Class A (2014–2025)
Financial flexibility index of Zhejiang Anglikang Pharmaceutical Co Ltd Class A from 2014 to 2025. Historical Financial Flexibility Index trend for Zhejiang Anglikang Pharmaceutical Co Ltd Class A across 12 annual periods. Check 002940 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Zhejiang Anglikang Pharmaceutical Co Ltd Class A Financial Flexibility Index by Year (2014–2025)
Zhejiang Anglikang Pharmaceutical Co Ltd Class A financial flexibility index by year from 2014 to 2025. Year-by-year free cash flow to debt coverage for Zhejiang Anglikang Pharmaceutical Co Ltd Class A. For the full cash flow conversion analysis, see Zhejiang Anglikang Pharmaceutical Co Ltd cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.27x | CN¥294.08 Million | CN¥244.13 Million | CN¥1.08 Billion | ▼ -8.3% |
| 2024 | 0.30x | CN¥348.06 Million | CN¥253.60 Million | CN¥1.18 Billion | ▼ -12.5% |
| 2023 | 0.34x | CN¥401.86 Million | CN¥276.91 Million | CN¥1.19 Billion | ▲ +26.7% |
| 2022 | 0.27x | CN¥253.57 Million | CN¥184.75 Million | CN¥949.93 Million | ▼ -43.0% |
| 2021 | 0.47x | CN¥284.97 Million | CN¥197.65 Million | CN¥608.64 Million | ▼ -9.0% |
| 2020 | 0.51x | CN¥289.58 Million | CN¥198.61 Million | CN¥562.78 Million | ▼ -34.4% |
| 2019 | 0.78x | CN¥289.08 Million | CN¥213.49 Million | CN¥368.51 Million | ▲ +94.1% |
| 2018 | 0.40x | CN¥201.78 Million | CN¥133.61 Million | CN¥499.27 Million | ▼ -16.7% |
| 2017 | 0.49x | CN¥248.56 Million | CN¥193.77 Million | CN¥512.41 Million | ▲ +16.0% |
| 2016 | 0.42x | CN¥167.56 Million | CN¥141.74 Million | CN¥400.56 Million | ▲ +29.0% |
| 2015 | 0.32x | CN¥173.69 Million | CN¥138.59 Million | CN¥535.63 Million | ▲ +68.6% |
| 2014 | 0.19x | CN¥98.93 Million | CN¥50.46 Million | CN¥514.36 Million | — |